Tirzepatide access
SnagRx vs Maximus: Which One Offers Tirzepatide? (2026)
SnagRx or Maximus? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
If SnagRx and Maximus are the two tabs still open, the deciding information is not on either homepage — it is in what happens after the first month.
Molecule availability is the fork here: SnagRx covers both semaglutide and tirzepatide, while Maximus publishes semaglutide alone. That matters most to anyone who may want to switch rather than simply escalate.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. Where a figure is not published, that is stated rather than estimated.
The short answer
- Lowest 12-month cost
- SnagRx — $828 against $1,596 at Maximus, on each provider's own best published pricing.
- Most predictable bill
- SnagRx — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Easiest to pay for
- SnagRx — Neither publishes financing; both expect the full amount monthly.
SnagRx vs Maximus: the specification
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| SnagRx | Maximus | |
|---|---|---|
| Advertised price | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan | $132.99/mo |
| Rate after promotions | $99/mo | $133/mo |
| Pricing structure | Flat rate at every dose | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Tirzepatide | $149/mo | Not published |
| Price transparency | Published upfront | Published upfront |
| Support model | No coaching program stated | No coaching program stated |
| Shipping | Free next-day UPS or FedEx in temperature-controlled packaging | Home delivery |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 9,860 | 2,896 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
The real cost: six months and twelve
The cheapest first month and the cheapest year are frequently different providers. The totals below are the honest version, built from the rates each provider publishes.
| SnagRx | Maximus | |
|---|---|---|
| First month | $99 | $133 |
| Months 2 onward | $99/mo | $133/mo |
| 6-month total | $594 | $798 |
| 12-month total | $1,188 | $1,596 |
| Best published plan | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr | No multi-month discount published |
The twelve-month spread is $768. That is the number to hold Maximus against: it has to justify roughly $64 extra every month.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
SnagRx publishes both, with tirzepatide at $149/mo. Maximus publishes compounded semaglutide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
The question to ask yourself is not which molecule you want now, but how much friction a change would create later.
A closer look at SnagRx
SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping. What it is really selling here is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly.
Practically: 5-minute intake, clinician review typically within 5 hours and always within 24, free next-day UPS or FedEx in temperature-controlled packaging, and a pricing model that is flat rate at every dose.
Ongoing care is 1:1 nursing staff plus a secure patient portal for refills and dose changes, and the medication list runs to compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
- Price locked flat at every dose and at renewal — no re-pricing during titration
- Names its four US 503A partner pharmacies and its clinician network (OpenLoop Health)
- States LegitScript certification, which patients can verify independently
SnagRx cons
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
- Heavy urgency marketing, including a countdown timer on the pricing page
The reservation worth holding, particularly next to Maximus: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
Inside the Maximus program
$132.99 per Month In this pairing, its distinguishing feature is a low flat rate with a simple direct-pay structure and nothing bolted on.
From signup to first shipment: telemedicine intake, no clinic visits, then home delivery. Billing follows a flat rate at every dose structure.
Support: prescriptions approved by licensed doctors, filled through U.S. pharmacies. The medications on offer are compounded semaglutide.
Maximus pros
- Simple, straightforward direct-pay model
- Convenient telemedicine access with no clinic visits
- Low flat rate at $132.99/month
- Medication filled through trusted U.S. pharmacies
Maximus cons
- Smallest patient base on this list, limited public reviews and track record
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Limited published detail on tirzepatide availability and program features
Read next to SnagRx, the weak point: the smallest patient base here, with limited published detail on tirzepatide.
Who each program is actually built for
Choose SnagRx if:
- the level of clinical contact suits you: 1:1 nursing staff plus a secure patient portal for refills and dose changes
- you would get real value from the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly
- the twelve-month total is what you are optimizing ($1,188 against $1,596)
- delivery works the way you want it to: free next-day UPS or FedEx in temperature-controlled packaging
Choose Maximus if:
- delivery works the way you want it to: home delivery
- you want the price you sign up at to survive titration
- the feature you would actually use: a low flat rate with a simple direct-pay structure and nothing bolted on
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
The trade-offs, stated plainly
On price. $99/mo against $133/mo. Maximus is asking you to pay for a low flat rate with a simple direct-pay structure and nothing bolted on; decide whether that is a line item you will use.
On clinical contact. 1:1 nursing staff plus a secure patient portal for refills and dose changes at SnagRx; prescriptions approved by licensed doctors, filled through U.S. pharmacies at Maximus. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
On medication. SnagRx covers compounded semaglutide and compounded tirzepatide; Maximus covers compounded semaglutide. Only SnagRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
On access. SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24 and free next-day UPS or FedEx in temperature-controlled packaging; Maximus advertises telemedicine intake, no clinic visits and home delivery. Coverage differs too — 48 states against not published — which decides the question before price does if you are in a restricted state.
What the evidence actually says
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
In SURMOUNT-1, tirzepatide reached a mean body-weight reduction of about 21% at the 15 mg dose over 72 weeks, per NEJM, SURMOUNT-1.
Weight regain after withdrawal is the documented pattern: the STEP 1 extension recorded participants returning to close to their starting weight a year after stopping, per Diabetes, Obesity and Metabolism.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
SnagRx vs Maximus: common questions
Which is cheaper to start, SnagRx or Maximus?
SnagRx, at $99 against $133. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Is SnagRx cheaper than Maximus?
Yes, on the ongoing rate. SnagRx runs $99/mo once promotional pricing ends, against $133/mo at Maximus — a difference of 34%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which costs less over a year, SnagRx or Maximus?
SnagRx, at roughly $828 for twelve months against $1,596 at Maximus, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
How fast can I start with SnagRx compared with Maximus?
SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24, with free next-day UPS or FedEx in temperature-controlled packaging. Maximus advertises telemedicine intake, no clinic visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do SnagRx and Maximus prescribe the same medication?
Both dispense compounded GLP-1 preparations. SnagRx lists compounded semaglutide and compounded tirzepatide and Maximus lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
Does SnagRx or Maximus offer tirzepatide?
SnagRx does, at $149/mo. Maximus publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
What happens if I stop taking the medication?
Neither SnagRx nor Maximus penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
The verdict
Strictly on cost, SnagRx takes it — $828 to $1,596 over twelve months.
Where Maximus justifies itself is a low flat rate with a simple direct-pay structure and nothing bolted on. Where it does not is anywhere the extra spend buys features you will never open.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- altRx vs SnagRxFinancing and HSA/FSA
- JoinFridays vs SnagRxBudget vs premium
- Enhance MD vs MaximusBudget vs premium
- Directmeds vs MaximusPublished price vs quote-only
- Wellmedr vs NoviTirzepatide access
- Wellmedr vs SnagRxTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by SnagRx or Maximus, and does not sell treatment. Read our ranking methodology.